» Articles » PMID: 32636225

Progressive Familial Intrahepatic Cholestasis Type 4 in an Indian Child: Presentation, Initial Course and Novel Compound Heterozygous Mutation

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2020 Jul 9
PMID 32636225
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A 15-year-old boy who had a history of on and off pruritus and jaundice since many years found to have a novel mutation in TJP2 gene. On examination, he had clubbing, splenomegaly, grade 3 oesophageal varices and short stature. Investigation revealed direct hyperbirubinemia with elevated liver enzymes with normal gamma-glutamyl transferase (GGT). Antinuclear antibody (ANA), smooth muscle antibody (SMA) anti-liver kidney microsomal (anti-LKM) and viral markers for hepatitis were negative. However, IgG was elevated and anti-smooth muscle antibody (ASMA) was weekly positive (1:20). He was also given a trial of steroid and azathioprine for 1 year on the basis of liver biopsy findings, raised IgG and positive ASMA but finding no improvement stopped. Genetic testing by next-generation sequencing found a novel compound heterozygous missense variation in exon 17 of the TJP2 gene confirming progressive familial intrahepatic cholestasis type 4 as the aetiology of cholestatic liver disease.

Citing Articles

A Novel Compound Heterozygous Mutation in Progressive Familial Intrahepatic Cholestasis (PFIC) 4: A Rare Case Report With Literature Review.

Pandey D, Chandnani S, Gandhi H, Vishal M, Rathi P Cureus. 2024; 16(11):e73927.

PMID: 39697951 PMC: 11654999. DOI: 10.7759/cureus.73927.


Progressive familial intrahepatic cholestasis type 4: a case report.

Abokandil M, Waheeb S, Zaghloul W, Abdelgawad M, Abdelhady M, Mansy M J Med Case Rep. 2024; 18(1):434.

PMID: 39243110 PMC: 11380191. DOI: 10.1186/s13256-024-04662-5.


A Rare Case of Progressive Familial Intrahepatic Cholestasis Type 4: A Case Report and Literature Review.

Halabi H, Kalantan K, Abdulhaq W, Alshaibi H, Almatrafi M Cureus. 2023; 15(10):e47276.

PMID: 38021987 PMC: 10656038. DOI: 10.7759/cureus.47276.


Newer variants of progressive familial intrahepatic cholestasis.

Vinayagamoorthy V, Srivastava A, Sen Sarma M World J Hepatol. 2022; 13(12):2024-2038.

PMID: 35070006 PMC: 8727216. DOI: 10.4254/wjh.v13.i12.2024.

References
1.
Kohler K, Zahraoui A . Tight junction: a co-ordinator of cell signalling and membrane trafficking. Biol Cell. 2005; 97(8):659-65. DOI: 10.1042/BC20040147. View

2.
Srivastava A . Progressive familial intrahepatic cholestasis. J Clin Exp Hepatol. 2015; 4(1):25-36. PMC: 4017198. DOI: 10.1016/j.jceh.2013.10.005. View

3.
Vij M, Shanmugam N, Reddy M, Sankaranarayanan S, Rela M . Paediatric hepatocellular carcinoma in tight junction protein 2 (TJP2) deficiency. Virchows Arch. 2017; 471(5):679-683. DOI: 10.1007/s00428-017-2204-1. View

4.
Zhou S, Hertel P, Finegold M, Wang L, Kerkar N, Wang J . Hepatocellular carcinoma associated with tight-junction protein 2 deficiency. Hepatology. 2015; 62(6):1914-6. PMC: 4626433. DOI: 10.1002/hep.27872. View

5.
Sambrotta M, Thompson R . Mutations in TJP2, encoding zona occludens 2, and liver disease. Tissue Barriers. 2015; 3(3):e1026537. PMC: 4574888. DOI: 10.1080/21688370.2015.1026537. View